81 resultsGlobal quest underway to speed COVID-19 vaccine trials
WHO committee calls for gene editing tools to be shared with poorer nations
BASF ups 2021 profit forecast for second time on higher prices, volumes
GSK rejects Elliott's demands for board change, consumer sale
EU-approved COVID-19 vaccines protect against Delta variant, says official
CureVac says speaking to EU about ideal region to use vaccine
CureVac COVID-19 vaccine records only 48% efficacy in final trial readout
Oxford researchers say they developed blood test predictor of vaccine efficacy
AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants-study
GSK's drugs arm to get $11 bln booster from consumer spin-off
GSK to boost spending power of pharma business post break-up
CureVac may let contractors make rival vaccines if own shot fails -CEO
CureVac crashes after COVID-19 vaccine underwhelms
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
BASF postpones Wintershall Dea oil and gas business IPO
AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial
EU adds another rare blood condition as side effect of AstraZeneca shot
REUTERS EVENTS GSK consumer arm confident that growth, cash flow will help with debt
EU clears Pfizer-BioNTech COVID-19 vaccine for adolescents
Bayer hit by failure to cap risk from weedkiller cases